Precision radiation blitz tested to fight tough lung cancers
NCT ID NCT01345851
Summary
This study is testing a new way to deliver radiation therapy along with standard chemotherapy for people with stage II or III non-small cell lung cancer that cannot be removed by surgery. The goal is to see if a more targeted, higher-dose radiation schedule can kill more cancer cells while trying to limit damage to healthy tissue. Researchers will find the safest, most effective dose and monitor how well the treatment controls the cancer and its side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.